Peptide IndexPeptide Index
Peptide Index
← Home

Reference Repository

Primary citations behind every peptide entry. Includes Phase III RCTs, mechanistic reviews, and observational/research-grade publications. 127 sources.

  1. 1.AbbVie. Lupron Depot Prescribing Information.Find on PubMed Link not opening? Search Google Scholar
  2. 2.ACOG Practice Bulletin No. 107: Induction of Labor. Obstet Gynecol. 2009;114:386-97.Find on PubMed Link not opening? Search Google Scholar
  3. 3.Amthor H et al. Follistatin complexes myostatin and antagonises myostatin-mediated inhibition of myogenesis. Dev Biol. 2004;270:19-30.Read published work Link not opening? Search Google Scholar
  4. 4.Anger JT et al. Pentosan polysulfate sodium for interstitial cystitis. Cochrane Database. 2010.Find on PubMed Link not opening? Search Google Scholar
  5. 5.Ashmarin IP et al. Semax in the treatment of stroke. Zh Nevrol Psikhiatr. 2005;105:24.Find on PubMed Link not opening? Search Google Scholar
  6. 6.AstraZeneca. SYMLIN (pramlintide) Prescribing Information.Find on PubMed Link not opening? Search Google Scholar
  7. 7.Baar MP et al. Targeted apoptosis of senescent cells via a FOXO4-p53 interfering peptide. Cell. 2017;169:132.Read published work Link not opening? Search Google Scholar
  8. 8.Barnes GD et al. Sustained cardiovascular actions of APJ agonism during renin-angiotensin system activation and in patients with heart failure. Circ Heart Fail. 2013;6:482-91.Read published work Link not opening? Search Google Scholar
  9. 9.Beck DE, Sweeney WB, McCarter MD; Ipamorelin 201 Study Group. Prospective, randomized, controlled, proof-of-concept study of the ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. Int J Colorectal Dis. 2014;29:1527-1534. Human phase 2 trial: no statistically significant benefit on the primary time-to-tolerated-meal outcome.Read published work Link not opening? Search Google Scholar
  10. 10.Blanes-Mira C et al. A synthetic hexapeptide (Argireline) inhibits neuronal exocytosis. Int J Cosmet Sci. 2002;24:303.Read published work Link not opening? Search Google Scholar
  11. 11.Boucher J et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005;146:1764-71.Read published work Link not opening? Search Google Scholar
  12. 12.Bowers CY. GH releasing peptides — clinical use. J Clin Endocrinol Metab. 1996;81:1577.Read published work Link not opening? Search Google Scholar
  13. 13.Brain CE, Hindmarsh PC, Brook CGD. Continuous subcutaneous GHRH(1-29)NH2 promotes growth over 1 year in short, slowly growing children. Clin Endocrinol (Oxf). 1990;32:157-163. Small human pediatric study; five of eight children completed a full year of treatment, limiting generalizability.Read published work Link not opening? Search Google Scholar
  14. 14.Buse JB et al. Exenatide once weekly vs twice daily (DURATION-1). Lancet. 2008;372:1240.Read published work Link not opening? Search Google Scholar
  15. 15.Camacho-Pereira J et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab. 2016;23:1127-39.Read published work Link not opening? Search Google Scholar
  16. 16.Castner SA et al. Longevity factor klotho enhances cognition in aged nonhuman primates. Nat Aging. 2023;3:931-7.Read published work Link not opening? Search Google Scholar
  17. 17.Chang CH et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110:774-80.Read published work Link not opening? Search Google Scholar
  18. 18.Chapman FA et al. The therapeutic potential of apelin in kidney disease. Nat Rev Nephrol. 2021;17:840-53.Read published work Link not opening? Search Google Scholar
  19. 19.ClinicalTrials.gov. Safety and efficacy of ipamorelin compared to placebo for recovery of gastrointestinal function. NCT01280344. Human phase 2 dose-finding trial registry; registration or completion alone does not establish efficacy.Read published work Link not opening? Search Google Scholar
  20. 20.ClinicalTrials.gov. Safety and efficacy of ipamorelin for management of post-operative ileus. NCT00672074. Human phase 2 trial registry corresponding to the Beck et al. report; this is not a separate positive efficacy study.Read published work Link not opening? Search Google Scholar
  21. 21.Cosman F et al. Romosozumab Treatment in Postmenopausal Osteoporosis (FRAME). N Engl J Med. 2016;375:1532.Read published work Link not opening? Search Google Scholar
  22. 22.Covarrubias AJ et al. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22:119-41.Read published work Link not opening? Search Google Scholar
  23. 23.Dalmasso G et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134:166-78.Read published work Link not opening? Search Google Scholar
  24. 24.De Mota N et al. Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci USA. 2004;101:10464-9.Read published work Link not opening? Search Google Scholar
  25. 25.Diamond LE et al. PT-141, a melanocortin agonist for sexual dysfunction. Int J Impot Res. 2004;16:51.Find on PubMed Link not opening? Search Google Scholar
  26. 26.Dollerup OL et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. Am J Clin Nutr. 2018;108:343-53.Read published work Link not opening? Search Google Scholar
  27. 27.Dorr RT et al. Evaluation of Melanotan-II, a superpotent cyclic melanotropic peptide. Life Sci. 1996;58:1777.Read published work Link not opening? Search Google Scholar
  28. 28.Dray C et al. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab. 2008;8:437-45.Read published work Link not opening? Search Google Scholar
  29. 29.Dubal DB et al. Life extension factor klotho enhances cognition. Cell Rep. 2014;7:1065-76.Read published work Link not opening? Search Google Scholar
  30. 30.Elhassan YS et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Rep. 2019;28:1717-28.Read published work Link not opening? Search Google Scholar
  31. 31.Eli Lilly. Humalog (insulin lispro) Prescribing Information.Read published work Link not opening? Search Google Scholar
  32. 32.Falutz J et al. Effects of tesamorelin on visceral fat in HIV-associated lipodystrophy. N Engl J Med. 2007;357:2359.Read published work Link not opening? Search Google Scholar
  33. 33.Frías JP et al. Tirzepatide versus Semaglutide Once Weekly in Type 2 Diabetes (SURPASS-2). N Engl J Med. 2021;385:503.Read published work Link not opening? Search Google Scholar
  34. 34.Garaci E et al. Thymosin α1: from basic research to clinical use. Expert Opin Biol Ther. 2007;7:1535.Read published work Link not opening? Search Google Scholar
  35. 35.Garvey WT et al. CagriSema in Adults with Overweight or Obesity (REDEFINE-1). N Engl J Med. 2025.Read published work Link not opening? Search Google Scholar
  36. 36.Gobburu JV, Agerso H, Jusko WJ, Ynddal L. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharm Res. 1999;16:1412-1416. Human pharmacology study in healthy men: acute GH release and drug exposure, not evidence of long-term benefit or safety.Read published work Link not opening? Search Google Scholar
  37. 37.Goldspink G. Mechano-Growth Factor: a target for hypertrophy & repair. J Musculoskelet Neuronal Interact. 2005;5:344.Find on PubMed Link not opening? Search Google Scholar
  38. 38.Goldstein AL et al. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012;12:37-51.Read published work Link not opening? Search Google Scholar
  39. 39.Goldstein AL et al. Thymosin β4: Therapeutic potential. Expert Opin Biol Ther. 2012;12:37-51.Read published work Link not opening? Search Google Scholar
  40. 40.Grant R et al. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Front Aging Neurosci. 2019;11:257.Read published work Link not opening? Search Google Scholar
  41. 41.Haidet AM et al. Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proc Natl Acad Sci USA. 2008;105:4318-22.Read published work Link not opening? Search Google Scholar
  42. 42.Hashimoto Y et al. A rescue factor for Alzheimer's disease: Humanin. Proc Natl Acad Sci. 2001;98:6336.Read published work Link not opening? Search Google Scholar
  43. 43.Heffernan M et al. The effects of human GH and its lipolytic fragment (AOD9604). J Clin Endocrinol Metab. 2001;86:5663.Read published work Link not opening? Search Google Scholar
  44. 44.Hu MC et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol. 2011;22:124-36.Read published work Link not opening? Search Google Scholar
  45. 45.Hummelink R et al. Intranasal administration of growth hormone-releasing hormone(1-29)-NH2 in children with growth hormone deficiency: effects on growth hormone secretion and growth. Acta Paediatr Suppl. 1993;388:23-26. Human pilot study in eight children; GH peaks did not translate into increased six-month height velocity.Read published work Link not opening? Search Google Scholar
  46. 46.Imbimbo BP et al. Hexarelin: a novel GH-releasing peptide. J Endocrinol Invest. 1994;17:325.Find on PubMed Link not opening? Search Google Scholar
  47. 47.Japp AG et al. Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure. Circulation. 2010;121:1818-27.Read published work Link not opening? Search Google Scholar
  48. 48.Japp AG et al. Vascular effects of apelin in vivo in man. J Am Coll Cardiol. 2008;52:908-13.Read published work Link not opening? Search Google Scholar
  49. 49.Jastreboff AM et al. Tirzepatide for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387:205.Read published work Link not opening? Search Google Scholar
  50. 50.Jastreboff AM et al. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — Phase 2. N Engl J Med. 2023;389:514.Read published work Link not opening? Search Google Scholar
  51. 51.Johansen PB et al. Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth Horm IGF Res. 1999;9:106-113. Animal study only: rat bone-growth findings do not establish therapeutic benefits in humans.Read published work Link not opening? Search Google Scholar
  52. 52.Khavinson VK et al. Epitalon peptide and telomerase activation. Bull Exp Biol Med. 2003;135:590.Read published work Link not opening? Search Google Scholar
  53. 53.Khavinson VK et al. Peptidergic regulation of aging. Adv Gerontol. 2014;27:257.Find on PubMed Link not opening? Search Google Scholar
  54. 54.Kidoya H et al. Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis. EMBO J. 2008;27:522-34.Read published work Link not opening? Search Google Scholar
  55. 55.Kingsberg SA et al. Bremelanotide for HSDD: Phase 3 RECONNECT Trials. Obstet Gynecol. 2019;134:899.Read published work Link not opening? Search Google Scholar
  56. 56.Kota J et al. Follistatin gene delivery enhances muscle growth and strength in nonhuman primates. Sci Transl Med. 2009;1:6ra15.Read published work Link not opening? Search Google Scholar
  57. 57.Kozlovskaya MM et al. Selank: anxiolytic and nootropic activity. Eksp Klin Farmakol. 2003;66:31.Find on PubMed Link not opening? Search Google Scholar
  58. 58.Kuba K et al. Impaired heart contractility in apelin gene-deficient mice associated with aging and pressure overload. Circ Res. 2007;101:e32-42.Read published work Link not opening? Search Google Scholar
  59. 59.Kuro-o M et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390:45-51.Read published work Link not opening? Search Google Scholar
  60. 60.Kuro-o M. The Klotho proteins in health and disease. Nat Rev Nephrol. 2019;15:27-44.Read published work Link not opening? Search Google Scholar
  61. 61.Kurosu H et al. Suppression of aging in mice by the hormone Klotho. Science. 2005;309:1829-33.Read published work Link not opening? Search Google Scholar
  62. 62.le Roux CW et al. Survodutide for Obesity — Phase 2 RCT. N Engl J Med. 2024;391:719.Read published work Link not opening? Search Google Scholar
  63. 63.Lee C et al. The mitochondrial-derived peptide MOTS-c regulates insulin sensitivity. Cell Metab. 2015;21:443.Read published work Link not opening? Search Google Scholar
  64. 64.Lee DK et al. Characterization of apelin, the ligand for the APJ receptor. J Neurochem. 2000;74:34-41.Read published work Link not opening? Search Google Scholar
  65. 65.Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA. 2001;98:9306-11.Read published work Link not opening? Search Google Scholar
  66. 66.Lee SJ. Quadrupling muscle mass in mice by targeting myostatin & follistatin. PLoS ONE. 2007;2:e789.Read published work Link not opening? Search Google Scholar
  67. 67.Leffler DA et al. Larazotide acetate for celiac disease — Phase 2b RCT. Gastroenterology. 2015;148:1311.Read published work Link not opening? Search Google Scholar
  68. 68.Leon J et al. Peripheral elevation of a klotho fragment enhances brain function and resilience in young, aging, and cognitively impaired mice. Cell Rep. 2017;20:1360-71.Read published work Link not opening? Search Google Scholar
  69. 69.Locatelli V, Torsello A. GHRP-6 review. Curr Pharm Des. 2004;10:2255.Find on PubMed Link not opening? Search Google Scholar
  70. 70.Luger TA et al. Anti-inflammatory potency of α-MSH/KPV. Ann N Y Acad Sci. 2003;994:133.Read published work Link not opening? Search Google Scholar
  71. 71.Luger TA et al. New insights into the functions of α-MSH and related peptides in the immune system. Ann N Y Acad Sci. 2003;994:133-40.Read published work Link not opening? Search Google Scholar
  72. 72.Malinda KM et al. Thymosin β4 accelerates wound healing. J Invest Dermatol. 1999;113:364-8.Read published work Link not opening? Search Google Scholar
  73. 73.Marso SP et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes (LEADER). N Engl J Med. 2016;375:311.Read published work Link not opening? Search Google Scholar
  74. 74.Marso SP et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes (SUSTAIN-6). N Engl J Med. 2016;375:1834-44.Read published work Link not opening? Search Google Scholar
  75. 75.Martens CR et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9:1286.Read published work Link not opening? Search Google Scholar
  76. 76.Massudi H et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One. 2012;7:e42357.Read published work Link not opening? Search Google Scholar
  77. 77.McCoy AT et al. Dihexa, a small molecule HGF mimetic enhances cognition. J Pharmacol Exp Ther. 2013;344:141.Read published work Link not opening? Search Google Scholar
  78. 78.Mendell JR et al. Follistatin gene therapy for Becker muscular dystrophy and sporadic inclusion body myositis (clinical trial program). Mol Ther. 2017;25:870-879.Read published work Link not opening? Search Google Scholar
  79. 79.Miller PD et al. Effect of Abaloparatide vs Placebo on New Vertebral Fractures (ACTIVE). JAMA. 2016;316:722.Read published work Link not opening? Search Google Scholar
  80. 80.Muresanu DF et al. Cerebrolysin in Acute Ischemic Stroke (CARS). Stroke. 2016;47:151.Read published work Link not opening? Search Google Scholar
  81. 81.Nass R et al. Effects of an oral ghrelin mimetic on body composition. Ann Intern Med. 2008;149:601.Read published work Link not opening? Search Google Scholar
  82. 82.Neelakantan H et al. Selective NNMT inhibitor (5-Amino-1MQ) reverses diet-induced obesity. Biochem Pharmacol. 2018;147:141.Read published work Link not opening? Search Google Scholar
  83. 83.Neer RM et al. Effect of parathyroid hormone on fractures and bone mineral density (Fracture Prevention Trial). N Engl J Med. 2001;344:1434.Read published work Link not opening? Search Google Scholar
  84. 84.Oliynyk S, Oh S. The Pharmacology of Actoprotectors: Practical Application for Improvement of Mental and Physical Performance. Biomol Ther. 2012;20:446-56.Read published work Link not opening? Search Google Scholar
  85. 85.Pickart L et al. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108.Read published work Link not opening? Search Google Scholar
  86. 86.Pickart L, Margolina A. Regenerative & Protective Actions of the GHK-Cu Peptide. Int J Mol Sci. 2018;19:1987.Read published work Link not opening? Search Google Scholar
  87. 87.Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19:1987.Read published work Link not opening? Search Google Scholar
  88. 88.Plata-Salaman CR et al. P21 (Cerebrolysin-derived) — neurogenesis review. CNS Drug Rev. 2007.Find on PubMed Link not opening? Search Google Scholar
  89. 89.Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab. 2018;27:529-47.Read published work Link not opening? Search Google Scholar
  90. 90.Raun K et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139:552.Read published work Link not opening? Search Google Scholar
  91. 91.Read C et al. International Union of Basic and Clinical Pharmacology. CVII. Structure and pharmacology of the apelin receptor with a recommendation that elabela/toddler is a second endogenous peptide ligand. Pharmacol Rev. 2019;71:467-502.Read published work Link not opening? Search Google Scholar
  92. 92.Rickels MR et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia. Diabetes Care. 2016;39:264.Read published work Link not opening? Search Google Scholar
  93. 93.Robinson LR et al. Topical palmitoyl pentapeptide (Matrixyl) clinical study. Int J Cosmet Sci. 2005;27:155.Read published work Link not opening? Search Google Scholar
  94. 94.Sanofi. DDAVP (desmopressin) Prescribing Information.Find on PubMed Link not opening? Search Google Scholar
  95. 95.Schoenenberger GA. DSIP: a still unresolved riddle. J Neural Transm. 1984;21:367.Find on PubMed Link not opening? Search Google Scholar
  96. 96.Schuelke M et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med. 2004;350:2682-8.Read published work Link not opening? Search Google Scholar
  97. 97.Semba RD et al. Plasma klotho and mortality risk in older community-dwelling adults. J Gerontol A Biol Sci Med Sci. 2011;66:794-800.Read published work Link not opening? Search Google Scholar
  98. 98.Sikiric P et al. BPC 157, a body protection compound: review. Curr Pharm Des. 2018;24:1990-2001.Read published work Link not opening? Search Google Scholar
  99. 99.Sikiric P et al. BPC 157, A Body Protection Compound: Review. Curr Pharm Des. 2018;24:1990-2001.Read published work Link not opening? Search Google Scholar
  100. 100.Skorupskaite K et al. Kisspeptin and reproductive function. Hum Reprod Update. 2014;20:485.Read published work Link not opening? Search Google Scholar
  101. 101.Sleep D et al. Non-covalent albumin-binding ligands for extending the circulating half-life of small biotherapeutics. Med Res Rev. 2019;39:715-762.Read published work Link not opening? Search Google Scholar
  102. 102.Smith PJ, Brook CGD. Growth hormone releasing hormone or growth hormone treatment in growth hormone insufficiency? Arch Dis Child. 1988;63:634-638. Human pediatric comparative study of GHRH(1-29); GH treatment produced a stronger growth response in the matched comparison.Read published work Link not opening? Search Google Scholar
  103. 103.Sorli SC et al. Apelin is a potent activator of tumour neoangiogenesis. Oncogene. 2007;26:7692-9.Read published work Link not opening? Search Google Scholar
  104. 104.Szeto HH. Cardiolipin-targeted peptide SS-31 (Elamipretide). Br J Pharmacol. 2014;171:2029.Read published work Link not opening? Search Google Scholar
  105. 105.Szokodi I et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, is a potent cardiac inotrope. Circ Res. 2002;91:434-40.Read published work Link not opening? Search Google Scholar
  106. 106.Tatemoto K et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun. 1998;251:471-6.Read published work Link not opening? Search Google Scholar
  107. 107.Teichman SL et al. Prolonged Stimulation of GH and IGF-I Secretion by CJC-1295. J Clin Endocrinol Metab. 2006;91:799.Read published work Link not opening? Search Google Scholar
  108. 108.Thorner MO et al. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. J Clin Endocrinol Metab. 1996;81:1189-1196. Human multicenter open-label study of GHRH(1-29); pediatric growth findings do not establish benefits in healthy adults.Read published work Link not opening? Search Google Scholar
  109. 109.Tomas FM et al. Long-R3-IGF-I promotes nitrogen retention in rats. J Endocrinol. 1993;137:413.Read published work Link not opening? Search Google Scholar
  110. 110.U.S. FDA. Bulk drug substances used in compounding — follistatin products are not approved and not on the 503A bulks list.Read published work Link not opening? Search Google Scholar
  111. 111.U.S. FDA. Bulk drug substances used in compounding under section 503A (nominations and evaluation status).Read published work Link not opening? Search Google Scholar
  112. 112.U.S. FDA. Certain bulk drug substances for use in compounding that may present significant safety risks (Category 2 list, includes BPC-157 and thymosin beta-4 fragments).Read published work Link not opening? Search Google Scholar
  113. 113.U.S. FDA. Determination that GEREF (sermorelin acetate) injections were not withdrawn from sale for reasons of safety or effectiveness. Federal Register. 2013;78:14095-14096. Regulatory notice about historical Geref products, not evidence for current compounded products or adult anti-aging use.Read published work Link not opening? Search Google Scholar
  114. 114.U.S. FDA. Novel drug approvals and investigational new drug information (no Klotho product approved).Read published work Link not opening? Search Google Scholar
  115. 115.Urakawa I et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006;444:770-4.Read published work Link not opening? Search Google Scholar
  116. 116.Vandamme D et al. A comprehensive summary of LL-37. Cell Immunol. 2012;280:22.Read published work Link not opening? Search Google Scholar
  117. 117.Verdin E. NAD+ in aging, metabolism, and neurodegeneration. Science. 2015;350:1208-13.Read published work Link not opening? Search Google Scholar
  118. 118.Vinel C et al. The exerkine apelin reverses age-associated sarcopenia. Nat Med. 2018;24:1360-71.Read published work Link not opening? Search Google Scholar
  119. 119.Wang W et al. Angiotensin-converting enzyme 2 metabolizes and partially inactivates pyr-apelin-13 and apelin-17: physiological effects in the cardiovascular system. Hypertension. 2016;68:365-77.Read published work Link not opening? Search Google Scholar
  120. 120.Wharton S et al. Daily Oral Orforglipron for Obesity — Phase 2. N Engl J Med. 2023;389:877.Read published work Link not opening? Search Google Scholar
  121. 121.Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384:989.Read published work Link not opening? Search Google Scholar
  122. 122.Wong F et al. Terlipressin plus Albumin for Hepatorenal Syndrome Type 1 (CONFIRM). N Engl J Med. 2021;384:818.Read published work Link not opening? Search Google Scholar
  123. 123.World Anti-Doping Agency. Prohibited List (S0 non-approved substances; S2 includes thymosin β4 and derivatives).Read published work Link not opening? Search Google Scholar
  124. 124.World Anti-Doping Agency. The Prohibited List (myostatin inhibitors and non-approved substances prohibited in sport).Read published work Link not opening? Search Google Scholar
  125. 125.Xiao B et al. Orally targeted delivery of tripeptide KPV via hyaluronic acid-functionalized nanoparticles efficiently alleviates ulcerative colitis. Mol Ther. 2017;25:1628-40.Read published work Link not opening? Search Google Scholar
  126. 126.Yamazaki Y et al. Establishment of sandwich ELISA for soluble alpha-Klotho measurement: age-dependent change of soluble alpha-Klotho levels in healthy subjects. Biochem Biophys Res Commun. 2010;398:513-8.Read published work Link not opening? Search Google Scholar
  127. 127.Yoshino M et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372:1224-9.Read published work Link not opening? Search Google Scholar
Sign in to save favorites & stacks

Educational reference only. Not medical advice. Consult a qualified clinician before starting any peptide protocol.

Non-FDA-approved peptides are for research use only. Not for human or animal consumption.